Stroke With Transfusions Changing to Hydroxyurea (SWiTCH) - Related Studies

Stroke With Transfusions Changing to Hydroxyurea (SWiTCH)

This study is currently recruiting participants.

Study NCT00122980. Last updated on August 7, 2008. Information provided by National Heart, Lung, and Blood Institute (NHLBI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Hemochromatosis
		Cerebrovascular Accident
		Anemia, Sickle Cell
		Hematologic Diseases

2	Additional conditions recognized in this trial
		Cerebral Infarction
		Stroke

3	More general conditions related to this trial
		Anemia
		Anemia, Hemolytic
		Anemia, Hemolytic, Congenital
		Brain Diseases
		Brain Infarction
		Brain Ischemia
		Cardiovascular Diseases
		Central Nervous System Diseases
		Cerebrovascular Disorders
		Genetic Diseases, Inborn
		Hemoglobinopathies
		Iron Metabolism Disorders
		Iron Overload
		Metabolic Diseases
		Metabolism, Inborn Errors
		Metal Metabolism, Inborn Errors
		Nervous System Diseases
		Vascular Diseases

4	Interventions listed in this trial
		Red Cell Transfusions
		Iron Chelation
		Hydroxyurea
		Phlebotomy

5	More general drug interventions related to this trial
		Antineoplastic Agents
		Antisickling Agents
		Enzyme Inhibitors
		Hematologic Agents
		Molecular Mechanisms of Pharmacological Action
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		National Heart, Lung, and Blood Institute (NHLBI)